HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.

Abstract
The systemic administration of an agonist antibody against glucocorticoid-induced tumor necrosis factor receptor related (GITR) protein has been shown to be effective in overcoming immune tolerance and promoting tumor rejection in a variety of murine tumor models. However, little is known regarding the functional consequence of ligation of GITR with its natural ligand (GITR-L) in the context of regulatory T cell (Treg) suppression in vivo. To determine the mechanism of GITR-L action in vivo, we generated a panel of tumor cell clones that express varying levels of GITR-L. The ectopic expression of GITR-L on the tumor cell surface was sufficient to enhance anti-tumor immunity and delay tumor growth in syngeneic BALB/c mice. Within the range examined, the extent of anti-tumor activity in vivo did not correlate with the level of GITR-L expression, as all clones tested exhibited a similar delay in tumor growth. The localized expression of GITR-L on tumor cells led to a significant increase in CD8+ T cell infiltration compared to the levels seen in control tumors. The increased proportion of CD8+ T cells was only observed locally at the tumor site and was not seen in the tumor draining lymph node. Depletion studies showed that CD8+ T cells, but not CD4+ T cells, were required for GITR-L mediated protection against tumor growth. These studies demonstrate that signaling between GITR-L and GITR in the tumor microenvironment promotes the infiltration of CD8+ T cells, which are essential for controlling tumor growth.
AuthorsJohn S Cho, Jeffrey V Hsu, Sherie L Morrison
JournalCancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 58 Issue 7 Pg. 1057-69 (Jul 2009) ISSN: 1432-0851 [Electronic] Germany
PMID19018533 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoid-Induced TNFR-Related Protein
  • Receptors, Nerve Growth Factor
  • Receptors, Tumor Necrosis Factor
  • Tnfrsf18 protein, mouse
  • Tnfsf18 protein, mouse
  • Tumor Necrosis Factors
Topics
  • Animals
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Line, Tumor
  • Colonic Neoplasms (immunology)
  • Female
  • Genetic Vectors
  • Glucocorticoid-Induced TNFR-Related Protein
  • Immune Tolerance
  • Mice
  • Mice, Inbred BALB C
  • Receptors, Nerve Growth Factor (immunology, metabolism)
  • Receptors, Tumor Necrosis Factor (immunology, metabolism)
  • T-Lymphocytes, Regulatory (immunology, metabolism)
  • Transfection
  • Tumor Necrosis Factors (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: